DPYSL2 and neuropathic pain: Considering this, a positive feedback mechanism of upregulated SUMOylation increasing Cdk5 activity, resulting in increased CRMP2 phosphorylation and facilitation of subsequent CRMP2 SUMOylation could contribute to neuropathic pain.